| Date | Time | Source | Headline | Symbol | Company |
| 04/30/2024 | 12:53PM | iHub Newswire | FeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia | | |
| 12/08/2005 | 11:01AM | PR Newswire (US) | ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 11/14/2005 | 9:11AM | PR Newswire (US) | ev3 Inc. and Micro Therapeutics, Inc. Announce Merger Agreement | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/27/2005 | 9:01AM | PR Newswire (US) | Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net Sales | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/27/2005 | 9:00AM | PR Newswire (US) | ev3 Inc. Reports Third Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/21/2005 | 10:00AM | PR Newswire (US) | ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/10/2005 | 10:30AM | PR Newswire (US) | ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/10/2005 | 9:30AM | PR Newswire (US) | Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc. | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/05/2005 | 2:04PM | PR Newswire (US) | Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 08/02/2005 | 5:51PM | PR Newswire (US) | Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 08/02/2005 | 5:48PM | PR Newswire (US) | ev3 Inc. Reports Second Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 07/27/2005 | 4:27PM | PR Newswire (US) | ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 07/21/2005 | 6:27PM | PR Newswire (US) | ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 07/21/2005 | 6:08PM | PR Newswire (US) | Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 07/06/2005 | 6:30PM | PR Newswire (US) | Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 04/28/2005 | 5:14PM | PR Newswire (US) | Micro Therapeutics Reports 50% Net Sales Increase for 2005 First Quarter | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 04/25/2005 | 1:28PM | PR Newswire (US) | Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 03/21/2005 | 4:57PM | PR Newswire (US) | ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical Trial | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/10/2005 | 3:23PM | PR Newswire (US) | Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/10/2005 | 7:45AM | PR Newswire (US) | Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/07/2005 | 6:40PM | PR Newswire (US) | Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 02/01/2005 | 7:00AM | PR Newswire (US) | Micro Therapeutics Receives $3.7 Million Payment | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 12/29/2004 | 12:13PM | PR Newswire (US) | Micro Therapeutics Consolidates Manufacturing Capabilities | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 12/06/2004 | 3:04PM | PR Newswire (US) | ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical Trial | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 11/10/2004 | 9:00AM | PR Newswire (US) | ev3 International Files Lawsuit Against Distributors in Hong Kong and Phoenix | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 11/04/2004 | 7:00AM | PR Newswire (US) | Micro Therapeutics Reports 2004 Third Quarter Financial Results | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 11/01/2004 | 3:24PM | PR Newswire (US) | Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4 | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 10/21/2004 | 11:47AM | PR Newswire (US) | FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long Stents | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 09/21/2004 | 9:01AM | PR Newswire (US) | ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft Use | NASDAQ:MTIX | Micro Therapeutics (MM) |
| 08/26/2004 | 12:33PM | PR Newswire (US) | ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting Procedures | NASDAQ:MTIX | Micro Therapeutics (MM) |